The First Case Report of 47,XXY/46,XX/46,XY Mosaic Klinefelter Syndrome Patient With Mixed Connective Tissue Disorder

Abstract

Klinefelter syndrome (KS) mosaicism 47,XXY/46,XX/46,XY is an extremely rare disorder. Mixed connective tissue disorder (MCTD) is a systemic rheumatological disease with overlapping characteristic features of systemic lupus erythematosus (SLE), systemic sclerosis (SSc), polymyositis (PM)/dermatomyositis (DM), and rheumatoid arthritis (RA). It contains a higher titer level of U1-RNP and anti-RNP antibodies. A 50-year-old man was referred to our clinic with gynecomastia, lower extremity rash, persistent fever, arthralgia, muscle weakness, dry eye and mouth, Raynaud’s phenomenon abnormal, and hormone levels. He was a follow-up patient for MCTD. Chromosome analysis of the patient revealed an abnormal karyotype of mos47,XXY/46,XX/46,XY. Fluorescence in situ hybridization (FISH) analysis indicated ish(SRYx1),(DZYx1)(DZX1x2)/ish (SRYx0),(DYZ1x0)(DZX1x2)/ish(SRYx1), (DZYx1)(DZX1x1). Although the prevalence of autoimmune diseases in Klinefelter syndrome is unknown, it is thought that the estimated frequency is higher than men, close levels to that of women. This might be explained by several genes that regulate the function of the immune system located on the X chromosome and the gene dosage mechanism that is the escape of X-inactivation in early embryogenesis for KS development. To the best of our knowledge, this is the first case to report a 47,XXY/46,XX/46,XY Klinefelter syndrome patient with MCTD.

Keywords

Klinefelter syndrome MCTD mosaicism cytogenetic analyses

Introduction

Klinefelter syndrome (KS) is the most frequently observed chromosomal disorder, with an estimated frequency of 1:500 to 1:1,000 in males. Although clinical features of KS have been widely varied, the disease is generally characterized by tall stature, eunuchoid skeleton, narrow shoulders, variable level of intelligence from low to normal IQ, small testes, gynecomastia, and infertility. Laboratory analysis of KS includes lower serum testosterone, higher serum follicle-stimulating hormone (FSH), and luteinizing hormone (LH) levels accompanied by impaired spermatogenesis (Lanfranco et al., 2004).

The most common form of KS is the regular type (47, XXY), which accounts for 80% of all cases. The other common forms of KS are 47,XX and, der(Y), 47,X, der(X), Y,48,XXXY, 48,XXYY, 49,XXXXY, 47,XXY/46,XY mosaicism (Groth et al., 2013; Lanfranco et al., 2004; Radicioni et al., 2010). Although 47,XXY/46,XY mosaicism constitutes 10% of all KS patients, nearly 15 cases with 47 XXY/46, XX mosaicism of KS have been reported, thus far.

KS patients have an increased risk of autoimmune diseases, including multiple sclerosis, acquired hypothyroidism, rheumatoid arthritis (RA), Sjogren’s syndrome (SSs), and systemic lupus erythematosus (SLE) (Fish, 2008; Gleicher & Barad, 2007). Mixed connective tissue disorder (MCTD) is a systemic rheumatological disease with overlapping features of SLE, SSs, polymyositis/dermatomyositis (PM/DM), and RA. It is characterized by higher titer level of U1-RNP and anti-RNP antibodies. Raynaud’s phenomenon (RP), arthralgias, muscle weakness, and swollen hands are the most frequently observed clinical indications of MCTD. The disease is less common in males than in females (Martínez-Barrio et al., 2018; Ortega-Hernandez & Shoenfeld, 2012; Pepmueller, 2016).

Although KS has an increased risk of some autoimmune diseases, the 47, XXY/46,XX/46,XY mosaicism of KS is an infrequent condition. Furthermore, only three MCTD cases have been previously reported in KS. However, no case has been reported with both mosaic KS features and MCTD. To the best of our knowledge, this is the first case to report a 47,XXY/46,XX/46,XY KS patient with MCTD.

Case Summary

Case History and Physical Examination

A 50-year-old man was referred to our clinic with gynecomastia, lower extremity rash, persistent fever, arthralgia, muscle weakness, dry eye and mouth, and RP. He was a follow-up patient for MCTD. In his medical history, it was recorded that physicians performed an angiographic procedure two times this year due to his persistent angina pectoris. His left three fingers were amputated due to cyanosis in 4 months. His physical examination detected a eunuchoid body, sparse axillary hair growth, pubic hair distribution of feminine type, small testes, bilateral gynecomastia, digital ulcers, telangiectasias on his face, and splenomegaly. Written informed consent was obtained from the patient for the publication of this case report.

Laboratory Findings

The patient’s hemogram and biochemical tests were normal. Serological findings, hormone levels, and thrombophilia test results are shown in Table 1. The other test results are as follows: growth hormone, 0.637 ng/mL (0.03–2.47); somatomedin-C levels, 45.91 ng/mL (55–248); anti-TPO, 8.17 IU/mL (0–34); and anti-Tg, 25.21 IU/mL (0–115). Doppler ultrasonography revealed that his right testicle was 0.7 mL and his left testicle was 0.3 mL. The spleen measured was 192 mm × 60 mm in abdominal ultrasonography, and the liver size was 146 mm. Furthermore, ultrasonography revealed a cystic area behind the posterior half of the urinary bladder. It was assessed as compatible with a Mullerian ductus cyst. Echocardiography revealed that the left ventricle ejection fraction was 55% (>52), and the aortic and mitral valve maximum gradients were 12 and 4 mmHg, respectively. These findings are compatible with increased left atrium size and a mild degree of mitral deficiency. DEXA analysis showed osteopenic lesions on the right femur and lumbar vertebrae. Barret’s esophagus was detected in samples taken from the esophagus during the endoscopic procedure.

Table 1.

The Comparison of Previously Reported Cases of Klinefelter Syndrome With MCTD and Our Case with 47,XXY/46,XX/47 XY

	Case 1	Case 2	Case 3	Our Case
Author	Ishihara et al.	Takeuchi et al.	Kasten et al.	Kalayci Yigin et al.
Year	1994	1999	2005	2020
Ethnicity	Asian (Japanese)	Asian (Japanese)	Caucasian	Caucasian
Karyotype	47, XXY	47, XXY	47, XXY	47,XXY/46,XX/47 XY
Overlapping connective tissue disorder	Sjogren’s syndrome	Sjogren’s syndrome	Sjogren’s syndrome	Sjogren’s syndrome
Age at the onset of MCTD	28	58	43	25
Clinical characteristics
Height	162 cm	162 cm	190 cm	172 cm
Weight	N/A	53 kg	80 kg	76 kg
Gynecomastia	+	+	+	+
Raynaud’s phenomenon	+	+	+	+
Joint abnormalities	+	+	+	+
Pulmonary system abnormalities	+	+	+	+
Intellectual level	Normal	Normal	Normal	Normal
Hematological abnormalities	+	Mild anemia	Mild anemia	Mild anemia
Thrombophilic event
FV Leiden	N/A	N/A	–	Heterozygote
MTHFR C677T	N/A	N/A	–	Heterozygote
MTHFR A1298C	N/A	N/A	–	Heterozygote
Factor XIII	N/A	N/A	–	Heterozygote
Ovotesticular dysfunction	N/A	N/A	N/A	Yes
Serological findings
Rheumatoid factor	–	5 IU/mL	70 IU/mL	54.5 IU/mL Cut off index 14 <
Antinuclear antibody	+1:2560 homogeneous speckled	+homogeneous speckled	1/5,120	(+)
Anti-RNP	Anti-RNP (+)	Anti-RNP (+)	Anti U1-RNP (+)	Anti U1-RNP (+)
Anti-Sm	(−)	(−)	(−)	1.7 U/mL^a
Anti-dsDNA(IgG)	(+)	(−)	(−)	5.28 IU/mL^a
Anti-SSA	1:64	(−)	(−)	4.43 IU/mL^a
Anti-SSB	1:1	(−)	(−)	1.19 IU/mL^a
Ant-CCP	N/A	N/A	N/A	5.28 IU/mL^a
Anti-Jo1	N/A	N/A	N/A	3.26 IU/mL^a
Antiphospholipid IgG	N/A	N/A	N/A	3.09 IU/mL^a
Antiphospholipid IgM	N/A	N/A	N/A	0.5 IU/mL^a
Laboratory analysis
AZFa,b,c deletion	N/A	N/A	N/A	(−)
Total protein	9.4 g/dL	7.5 g/dL	N/A	5.8 g/dL
Albumin	2.8 g/dL	4.4 g/dL	N/A	3.45 g/dL
Globin	6.6 g/dL	N/A	N/A	NA
Hormonal status
FSH	28.9 mIU/mL (2.9–8.2)	91.9 mIU/mL (2.9–8.2)	20.6 mIU/mL (1.0–8.0)	21.21 mIU/mL (1.6–12.4)
LH	13.5 mIU/mL (1.8–5.2)	42.1 mIU/mL (1.8–5.2)	23.8 mIU/mL (2.0–12.0)	33.34 mIU/mL (0.8–6)
Total testosterone	3.1 ng/mL (3.8–9.9)	14.5 ng/mL (25–110)	2.0 ng/mL (2.8–8.0)	53.25 ng/dL (55–248)
Estradiol	<20 pg/mL	N/A	N/A	(?)
GH	N/A	2.22 ng/mL (<0.42)	N/A	0.637 ng/mL (0.03–2.47)
Somatomedin-C	N/A	N/A	N/A	45.91 ng/mL (55–248)
PRL	N/A	24.6 ng/mL (1.7–10)	N/A	24 ng/mL (4.1–15.2)
DHEA-SO4	344 ng/mL (400–3,500)	296 ng/mL (400–3,500)

Note. MCTD = mixed connective tissue disorder; FSH = follicle-stimulating hormone; LH: luteinizing hormone; GH: growth hormone; PRL: prolactine; DHEA-SO4: dehydroepiandrosterone sulfate.

Negative <12 IU/mL, borderline 12 to 18 IU/mL, positive >18 IU/mL.

Cytogenetic and Molecular Cytogenetics Analysis

Peripheral venous blood was taken from the patient for chromosome and fluorescence in situ hybridization (FISH) analysis with heparin and a 72-hr lymphocyte culture was performed at 37°C in phytohemagglutinin-induced cell culture. Metaphase preparations were obtained after the culture was stained using the GTG banding method (G-bands by Tripsin using Giemsa) and karyotype analyses were described according to the International System for Human Cytogenetic Nomenclature. Overall, 100 metaphases were analyzed. Chromosomal analysis of the patient revealed mos47, XXY[85]/46,XX[4]/46, XY[13] (Figure 1A).

Figure 1.

Results of Karyotype and FISH Analysis in Mosaic KS Patient. (A) Conventional Cytogenetic Analysis Showed a 47,XXY/46,XX/46,XY and (B) Interphase FISH Detected XXY Signals in 92% of Cells Analyzed and XX Signals in 5%, and XY Signals in the Remaining 3%

Peripheral blood was subjected to a short-term culture for 72 hr to obtain metaphase spreads for standard cytogenetic banding analyses (Verma & Babu, 1989). For FISH analysis, the prepared slides were dehydrated in 70%, 85%, and 100% ethanol (5 min each) and allowed to air dry. A probe mix was applied to the preparations. The preparations were denatured for 1 to 5 min at 73°C±1°C and incubated overnight at 37°C in a moist chamber. Post-hybridization washes were carried out 3 times (5 min each) in 2× SSC/50% formamide and twice in 2× SSC (5 min each) at 40°C. The slides were counterstained with propidium iodide or 4,6-diamidine, 2-phenylindole dihydrochloride (DAPI) solution. They were examined with fluorescence microscopy (Carl Zeiss, Germany).

FISH analysis indicated ish(SRYx1),(DZYx1)(DZX1x2)[92/100]/ish (SRYx0),(DYZ1x0)(DZX1x2)[5/100]/ ish(SRYx1), (DZYx1)(DZX1x1)[3/100] (Figure 1B).

Molecular Analysis

The peripheral blood sample was obtained using an EDTA tube, and genomic DNA isolation was performed according to standard techniques (Wizard Genomic DNA; Promega, Madison, WI, USA). For automatic DNA fragment analysis, ST multiplex amplification, including the AMXY marker and 5-dye fluorescent system, was used with electrophoresis (Chr. X: 104bp, Chr. Y: 109bp; Xp22.1, Yp11.2). Samples were evaluated using a genetic analyzer (Applied Biosystems 3500 ABI PRISM®). The Evaluated STS regions were sY82, sY83, sY84, sY86, sY88, and sY1065 for AZFa region; sY105, sY121, sY127, sY134, sY143, and sY153 for AZFb region; sY1191, sY1291, sY254, and sY255 for the AZFc regions. The ZFX/ZFY regions and terminal sY160 regions were used as an internal control. These regions were amplified and fragmented and analyzed. Y-microdeletion analysis has not detected any deletions in the previously explained SRY, AZFa, AZFb, and AZFc regions. Segregation analyses could not be performed because the parents were not living.

Discussion

As individuals with KS are phenotypically normal at birth, physicians rarely diagnose individuals during this period. Approximately 10% of KS patients can be diagnosed in the prepubertal period, and 25% are diagnosed during their lifetime. Due to the mild and variable phenotype, some individuals cannot even be diagnosed for life (Berglund et al., 2019). Many KS patients experience infertility, the primary clinical manifestation of KS that signals a referral for medical testing (Eberl et al., 2005). However, the mosaic form of KS is not characterized by infertility, as seen in our patient with four children, two sons and two girls, and a normal Y-microdeletion analysis.

Autoimmune diseases (ADs) are complex heterogeneous disorders with diverse factors influencing pathogenesis, such as genes, the immune system, and the environment. Although ADs are frequently seen in the general population, the prevalence of ADs in KS is unknown. A few hypotheses attempt to explain the mechanism of ADs in KS. One proposes an escape from X-inactivation and gene dosage (Seminog et al., 2015). Due to the gene dosage effect, X-overexpression may cause an increased gene dosage, leading to susceptibility to AD (Fujimoto et al., 2015). Another hypothesis poses that the genes responsible for controlling immune regulation are located in X chromosomes (Seminog et al., 2015). Many studies in the literature showed overexpression of genes in the X-chromosomes and ADs (Golks et al., 2007; Jacob et al., 2009; Kaufman et al., 2013; Shen et al., 2010). The last common hypothesis explains how ADs are more common in females than in males due to a potential association between high estrogen levels and reduced T-cell immune response.

MCTD is an AD that manifests in a mixture of SS, SLE, and RA (Ortega-Hernandez & Shoenfeld, 2012). Three previously reported cases involved a regular type KS with MCTD; all three subjects suffered from Raynaud’s phenomenon, as well as pulmonary, hematologic, and rheumatological manifestations with serological findings (Table 1) (Ishihara et al., 1994). Although SS-A and SS-B were negative in our patient, the other manifestations meet the American-European consensus criteria for Sjogren’s syndrome (Fazaa et al., 2014).

KS patients have a high risk of malignancy and thromboembolic conditions, and their symptoms should be monitored accordingly (Erkal et al., 2018). Because KS patients may develop ovarian and testicular tissues within the same gonad or separately, KS patients should undergo a physical examination or ultrasonography. In addition, the results of these exams could reveal reverse gonadal tissue or its remnants, both of which might be predisposed to malignancy. Therefore, early diagnosis and surgical procedures are vital in managing KS patients (Talreja et al., 2015).

Our patient had Mullerian cysts. Generally, Mullerian cysts are accepted as benign tumors; however, a malign transformation of Mullerian cysts is reported in the literature. One study notes a roughly 2.5- to 3.5-fold increase in hematological malignancy, leukemia, and lymphoma risk in KS patients (Ji et al., 2016). Both low-androgen levels and FV Leiden mutations are highly predisposed to thromboembolic and cardiac events. Androgen therapy may have a favorable outcome on thrombophilia and MCTD (Chang et al., 2020; Hussein et al., 2020). Due to our patient’s mild anemia and unexplained high level of leukocyte levels, we performed JAK2 and BCR/ABL real-time PCR analysis, and they were normal. However, we suggested a routine follow-up due to our patient’s increased risk of malignancy.

To conclude, although the prevalence of ADs in KS is unknown, it is thought that the prevalence of ADs in KS is more likely in men whose estradiol and testosterone levels are similar to those found in women; the estimated frequency is higher than in men, close levels to that of women (Seminog et al., 2015). This might be explained by several genes that regulate the function of the immune system located on the X chromosome and the gene dosage mechanism that escapes X-inactivation during early embryogenesis for KS development. To the best of our knowledge, our case is the first case report of 47,XXY/46,XX/46,XY with MCTD.

Footnotes

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Ethical Approval

Written informed consent was obtained from the patient to publish this case report.

ORCID iD

Mehmet Seven

References

Berglund

Viuff

M. H.

Skakkebæk

Chang

Stochholm

Gravholt

C. H.

(2019). Changes in the cohort composition of turner syndrome and severe non-diagnosis of Klinefelter, 47,XXX and 47,XYY syndrome: A nationwide cohort study. Orphanet Journal of Rare Diseases, 14(1), Article 16. https://doi.org/10.1186/s13023-018-0976-2

Chang

Christiansen

C. F.

Bojesen

Juul

Münster

A. M. B.

Gravholt

C. H.

(2020). Klinefelter syndrome and testosterone treatment: A national cohort study on thrombosis risk. Endocrine Connections, 9(1), 34–43. https://doi.org/10.1530/EC-19-0433

Eberl

M. M.

Baer

M. R.

Mahoney

M. C.

Sait

S. N. J.

Block

A. M. W.

Farrell

C. D.

(2005). Unsuspected Klinefelter syndrome diagnosed during oncologic evaluation: A case series. Journal of the American Board of Family Practice, 18(2), 132–139. https://doi.org/10.3122/jabfm.18.2.132

Erkal

Kalayci Yigin

Palanduz

Dasdemir

Seven

(2018). The effect of PAI-1 gene variants and PAI-1 plasma levels on development of thrombophilia in patients with Klinefelter syndrome. American Journal of Men’s Health, 12(6), 2152–2156. https://doi.org/10.1177/1557988318801158

Fazaa

Bourcier

Chatelus

Sordet

Theulin

Sibilia

Gottenberg

J.-E.

(2014). Classification criteria and treatment modalities in primary Sjögren’s syndrome. Expert Review of Clinical Immunology, 10(4), 543–551. https://doi.org/10.1586/1744666X.2014.897230

Fish

E. N.

(2008). The X-files in immunity: Sex-based differences predispose immune responses. Nature Reviews. Immunology, 8(9), 737–744. https://doi.org/10.1038/nri2394

Fujimoto

Ikeda

Nakamura

Iwamoto

Furuta

Nakajima

(2015). Development of mixed connective tissue disease and Sjögren’s syndrome in a patient with trisomy X. Lupus, 24(11), 1217–1220. https://doi.org/10.1177/0961203315580873

Gleicher

Barad

D. H.

(2007). Gender as risk factor for autoimmune diseases. Journal of Autoimmunity, 28(1), 1–6. https://doi.org/10.1016/j.jaut.2006.12.004

Golks

Tran

T. T. T.

Goetschy

J. F.

Guerini

(2007). Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO Journal, 26(20), 4368–4379. https://doi.org/10.1038/sj.emboj.7601845

10.

Groth

K. A.

Skakkebæk

Høst

Gravholt

C. H.

Bojesen

(2013). Klinefelter syndrome: A clinical update. Journal of Clinical Endocrinology and Metabolism, 98(1), 20–30. https://doi.org/10.1210/jc.2012-2382

11.

Hussein

T. M.

Abd Elmoaty Elneily

Mohamed Abdelfattah Elsayed

El-Attar

L. M.

(2020). Genetic risk factors for venous thromboembolism among infertile men with Klinefelter syndrome. Journal of Clinical and Translational Endocrinology, 20, Article 100228. https://doi.org/10.1016/j.jcte.2020.100228

12.

Ishihara

Yoshimura

Nakao

Kanakura

Kanayama

Matsuzawa

(1994). T cell abnormalities in mixed connective tissue disease complicated with Klinefelter’s syndrome. Internal Medicine, 33(11), 714–717. https://doi.org/10.2169/internalmedicine.33.714

13.

Jacob

C. O.

Zhu

Armstrong

D. L.

Yan

Han

Zhou

X. J.

Thomas

J. A.

Reiff

Myones

B. L.

Ojwang

J. O.

Kaufman

K. M.

Klein-Gitelman

McCurdy

Wagner-Weiner

Silverman

Ziegler

Kelly

J. A.

Merrill

J. T.

Harley

J. B.

Mohan

(2009). Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America, 106(15), 6256–6261. https://doi.org/10.1073/pnas.0901181106

14.

Zöller

Sundquist

(2016). Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: A national cohort study. International Journal of Cancer, 139(4), 754–758. https://doi.org/10.1002/ijc.30126

15.

Kaufman

K. M.

Zhao

Kelly

J. A.

Hughes

Adler

Sanchez

Ojwang

J. O.

Langefeld

C. D.

Ziegler

J. T.

Williams

A. H.

Comeau

M. E.

Marion

M. C.

Glenn

S. B.

Cantor

R. M.

Grossman

J. M.

Hahn

B. H.

Song

Y. W.

C. Y.

James

J. A.

Tsao

B. P.

(2013). Fine mapping of Xq28: Both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Annals of the Rheumatic Diseases, 72(3), 437–444. https://doi.org/10.1136/annrheumdis-2012-201851

16.

Lanfranco

Kamischke

Zitzmann

Nieschlag

P. E.

(2004). Klinefelter’s syndrome. Lancet, 364(9430), 273–283. https://doi.org/10.1016/S0140-6736(04)16678-6

17.

Martínez-Barrio

Valor

López-Longo

F. J.

(2018). Facts and controversies in mixed connective tissue disease. Medicina Clinica, 150(1), 26–32. https://doi.org/10.1016/j.medcli.2017.06.066

18.

Ortega-Hernandez

O. D.

Shoenfeld

(2012). Mixed connective tissue disease: An overview of clinical manifestations, diagnosis and treatment. Best Practice and Research: Clinical Rheumatology, 26(1), 61–72. https://doi.org/10.1016/j.berh.2012.01.009

19.

Pepmueller

P. H.

(2016). Undifferentiated connective tissue disease, mixed connective tissue disease, and overlap syndromes in rheumatology. Missouri Medicine, 113(2), 136–140.

20.

Radicioni

A. F.

Ferlin

Balercia

Pasquali

Vignozzi

Maggi

Foresta

Lenzi

(2010). Consensus statement on diagnosis and clinical management of Klinefelter syndrome. Journal of Endocrinological Investigation, 33(11), 839–850. https://doi.org/10.1007/BF03350351

21.

Seminog

O. O.

Seminog

A. B.

Yeates

Goldacre

M. J.

(2015). Associations between Klinefelter’s syndrome and autoimmune diseases: English national record linkage studies. Autoimmunity, 48(2), 125–128. https://doi.org/10.3109/08916934.2014.968918

22.

Shen

Deng

Qian

Zhao

Kaufman

K. M.

Y. L.

C. Y.

Tang

Chen

J. Y.

Yang

Wong

Kawasaki

Tsuchiya

Sumida

Kawaguchi

Howe

H. S.

Mok

M. Y.

Bang

S. Y.

Tsao

B. P.

(2010). Sex-specific association of X-linked toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America, 107(36), 15838–15843. https://doi.org/10.1073/pnas.1001337107

23.

Talreja

Banerjee

Yadav

S. S.

Tomar

(2015). A rare case of lateral ovotesticular disorder with Klinefelter syndrome mosaicism 46, XX/47, XXY: An unusual presentation. Urology Annals, 7(4), 520–523. https://doi.org/10.4103/0974-7796.164855

24.

Verma

R. S.

Babu

(1989). Human chromosomes: Manual of basic techniques. Pergamon Press.